FITC Plus Anti-Human CD42b (AK2) Mouse IgG2a Recombinant Antibody

CD42b Uni-rAbTM Recombinant Antibody for FC
Cat No. FITC-65588

产品说明书

CloneNo. AK2

宿主/亚型

Mouse / IgG2a

种属反应性

human

应用

FC

GP1BA, GP1B, CD42b alpha, BSS, Antigen CD42b-alpha

缓冲液配方:  PBS and Azide
PBS and Azide
规格: 

-/ -


经过测试的应用

Positive FC detected inhuman peripheral blood platelets

推荐稀释比

应用推荐稀释比
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 ul per 10^6 cells in a 100 µl suspension or 5 ul per 100 µl of whole blood.
Sample-dependent, Check data in validation data gallery.

产品信息

FITC-65588 targets CD42b in FC applications and shows reactivity with human samples.

经测试应用 FC Application Description
经测试反应性 human
免疫原 Human platelets 种属同源性预测
宿主/亚型 Mouse / IgG2a
抗体类别 Recombinant
产品类型 Antibody
全称 glycoprotein Ib (platelet), alpha polypeptide
别名 GP1BA, GP1B, CD42b alpha, BSS, Antigen CD42b-alpha
计算分子量 626 aa, 69 kDa
GenBank蛋白编号BC027955
基因名称 CD42b
Gene ID (NCBI) 2811
ENSEMBL Gene IDENSG00000185245
偶联类型 FITC Plus Fluorescent Dye
最大激发/发射波长495 nm / 524 nm
形式 Liquid
纯化方式Protein A purification
储存缓冲液 PBS with 0.09% sodium azide , pH 7.3
储存条件Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

背景介绍

CD42b, also known as platelet glycoprotein Ib alpha chain (GPIb alpha), is a type I transmembrane glycoprotein of 135-145 kDa (PMID: 2656709). It is expressed on platelets and megakaryocytes. CD42b and CD42c (GPIb beta) are linked by a disulphide bond to form GPIb (PMID: 7660135). GPIb forms a noncovalent complex with CD42a (GPIX) and CD42d (GPV) and acts as a receptor for von Willebrand factor (vWF) and thrombin (PMID: 7660135; 3759960). The GPIb-V-IX complex mediates vWF-dependent platelet adhesion to blood vessels. Defects in the expression of CD42b result in Bernard-Soulier syndromes and platelet-type von Willebrand disease (PMID: 9371310).

实验方案

Product Specific Protocols
FC protocol for FITC Plus CD42b antibody FITC-65588Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...